This interactive case study will cover how to test for HER2 mutations in NSCLC, interpret biomarker results, and effectively communicate findings to patients as an APP.
After completing this activity, you will be able to:
Support multidisciplinary teams by applying current evidence on biomarker testing and HER2-targeted therapies to real-world patient care
Activity overview
These case studies are available with video and text. The activity is best supported via a computer or mobile device with current versions of the following browsers: Mozilla Firefox, Google Chrome, or Safari.
Release date: 10th July 2026
Estimated time to complete: 20 minutes
Accreditation
This continuing education activity has been approved by the International Council of Nurses (ICN) for the award of 0.25 International Continuing Nursing Education Credits (ICNECs) upon successful completion of the accredited course.
How to claim your credits
To claim your credits, you will need to complete the activity module, then fill out the short evaluation form at the end of the module. Physicians should claim only the credit commensurate with the extent of their participation in the activity.